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Abstract
The chemokine (C-C motif) receptor 2B (CCR2B) is one of the two isoforms of the receptor for monocyte chemoattractant
protein-1 (CCL2), the major chemoattractant for monocytes, involved in an array of chronic inflammatory diseases.
Employing the yeast two-hybrid system, we identified the actin-binding protein filamin A (FLNa) as a protein that associates
with the carboxyl-terminal tail of CCR2B. Co-immunoprecipitation experiments and in vitro pull down assays demonstrated
that FLNa binds constitutively to CCR2B. The colocalization of endogenous CCR2B and filamin A was detected at the surface
and in internalized vesicles of THP-1 cells. In addition, CCR2B and FLNa were colocalized in lamellipodia structures of CCR2B-
expressing A7 cells. Expression of the receptor in filamin-deficient M2 cells together with siRNA experiments knocking down
FLNa in HEK293 cells, demonstrated that lack of FLNa delays the internalization of the receptor. Furthermore, depletion of
FLNa in THP-1 monocytes by RNA interference reduced the migration of cells in response to MCP-1. Therefore, FLNa
emerges as an important protein for controlling the internalization and spatial localization of the CCR2B receptor in different
dynamic membrane structures.
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Introduction
Chemokines and their receptors play an important role in the
immune system by mediating translocation of leukocytes towards
sites of inflammation [1]. The activation of chemokine receptors
induces extensive cellular morphological changes through the
rearrangement of the actin cytoskeleton, among other structures.
Monocyte chemoattractant protein 1 (MCP-1/CCL2) is a
chemokine secreted by numerous cell types including endothelial
cells, epithelial cells, vascular smooth muscle and hematopoietic
cells, and is a potent chemoattractant for monocytes and
lymphocytes [1]. CCL2 is responsible for monocyte infiltration
in a variety of chronic inflammatory diseases such as rheumatoid
arthritis, atherosclerosis and multiple sclerosis, and has recently
been implicated in cancer [2].
A key issue in the process of chemokine-induced cell migration
is to understand the connection between chemokine receptor
activation and cytoskeletal reorganization. Similar to other
chemokine receptors, stimulation of the CCL2-receptor, CCR2,
results in the activation of a plethora of intracellular signal
transduction cascades, which leads to actin filament reorganiza-
tion, cell polarization and cell movement [3]. The C-terminal
intracellular domain of CCR2 is critical for mediating receptor
desensitization and internalization [4]. Phosphorylation by GRK2
favors the recruitment of the arrestin proteins, leading to the
subsequent uncoupling from G proteins and loss of receptor
responsiveness [5,6,7]. Subsequently, the regulation by GRK and
arrestin promotes clathrin-mediated internalization of inactivated
receptors to endosomal compartments. Small changes in the levels
of GRK2 expression can have a marked effect on the chemokine
response [8,9]. Interestingly, the protein FROUNT, which binds
to the C-terminal tail of CCR2B, is involved in clustering of the
receptor in the plasma membrane, which is important for
chemotaxis [10]. Therefore, the C-terminus of CCR2B is
indispensable for receptor endocytosis and recycling, and subse-
quent chemotaxis.
Filamin A (FLNa, cytoskeletal protein ABP-280) is an
ubiquitously expressed dimeric actin cross-linking phosphoprotein
which promotes orthogonal branching of actin filaments [11]. It
also establishes critical links between the submembranous actin gel
and integral membrane proteins, which stabilize the membrane,
particularly during changes in cell shape associated with motility
and migration. FLNa is composed of an N-terminal actin-binding
domain, a C-terminal homodimerization domain, and a central
rod-like backbone comprising 24 tandem repeats, each approxi-
mately 96 aa in length. Many different protein partners have been
identified for FLNa. These include not only transmembrane
proteins such as D2 and D3 dopamine receptors [12] and
potassium channels [13], but also intracellular signaling molecules
such as the Rho family of GTPases [14]. The ability to aggregate
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signaling proteins is potentially important not only in the
stabilization of receptors at the cell surface, but also in cell signal
integration and cell migration.
As mentioned above, the C-terminal tail of chemokine receptors
is essential for receptor desensitization, internalization and
chemotaxis. To search for novel proteins, which could interact
with the CCR2B receptor, we employed the yeast two-hybrid
assay using the C-terminal tail of the receptor as a bait to screen a
human leukocyte cDNA library. We identified FLNa as an
interacting partner of CCR2B and demonstrate that FLNa is
essential for the initial step of receptor endocytosis after ligand
stimulation. The identification of filamin A as a protein binding to
the CCR2B sheds new light for understanding the physiological
processes elicited by CCL2, and possibly, by other chemokines.
Results
The C-terminal tail of the CCR2B receptor interacts with
the actin-binding protein, filamin A
A yeast two-hybrid approach was used to identify proteins that
bind to the CCR2B receptor tail. Utilizing the pGBKT7-
CCR2B47tri (aa 314–360) as bait, around 6610
5 independent
colonies of a human leukocyte library were screened and multiple
clones were isolated. To eliminate false positives, clones were re-
streaked and several clones were rejected, since the interactions
were found to be non-specific. One of the positive clones was
found to encode a partial cDNA representing repeats 19–24 of
FLNa (aa 2085–2647) (Figure 1A and B). FLNa is an actin-binding
protein that regulates the assembly of actin filaments into dynamic
3D networks [15]. Interestingly, this region of FLNa, known as
Rod 2 domain, has been found to bind various membrane
proteins, among them several receptors [11]. To confirm the
interaction between the FLNa peptide and the CCR2B-tail,
pGBKT7-CCR2B47tri was co-transformed into S. cerevisiae strain
AH109 together with the fragment found in the screening (repeats
19–24) and other fragments (16–19, 18, 23 or 24) of FLNa fused to
the Gal4 activation domain. None of the filamin constructs or the
receptor C-terminal tail supported growth by themselves.
However, FLNa constructs encoding repeats 19–24 or 16–19,
together with receptor C-terminal tail, supported growth, whereas
individual repeats 18, 23 and 24 were negative (Figure 1A, middle
and lowest panels) suggesting that the CCR2B-tail binds to a
region of FLNa that comprises at least repeat 19.
To determine whether the CCR2B-tail could interact with full-
length FLNa, we analyzed the interaction between a CCR2B-tail
peptide, synthesized in an in vitro transcription and translation
system and FLNa protein present in A7 cells. M2-filamin A
deficient cells were used as control. As can be seen (Figure 2A,
upper panel), FLNa was pulled down with the CCR2B tail only in
the presence of the A7 cell lysates, and no FLNa was
immunoprecipitated from the M2 cell lysates. Further corrobora-
tion for the interaction was obtained by expressing the full length
CCR2B tagged with the FLAG epitope in HEK293 cells and
performing pull-down experiments to examine association with
endogenous FLNa. Both monomer and dimer forms of the
CCR2B were detected in the blot (Figure 2B, lane 2B). FLNa was
co-immunoprecipitated together with CCR2B, whilst a very faint
band was detected in cells transfected with empty vector
(Figure 2B, lane C), probably due to unspecific antibody binding.
Since the low levels of receptor expressed in monocytic cells
precluded us from performing immunoprecipitation studies in
those cells, we attempted to visualize the distribution of CCR2 and
FLNa proteins in two human monocytic cell lines, Mono Mac 1
and THP-1, which endogenously express the CCR2 receptor [9]
by immunofluorescence. Monocytes show expression of the
receptor at the plasma membrane and also some diffuse staining
in the cytoplasm (Figure 2C). FLNa colocalizes with the receptor
preferentially at the plasma membrane in both cell lines. Taken
together, these findings demonstrate that CCR2B associates with
FLNa under basal conditions.
Colocalization of CCR2B and FLNa in the leading edges of
migrating cells
To investigate the possible function of FLNa, we studied the
localization of FLAG-tagged CCR2B receptor in FLNa-repleted
A7 cells and FLNA-deficient M2 cells. Figure 3A shows a
representative A7 cell where the receptor is diffusely distributed
on the cell surface. Some perinuclear and cytoplasmic staining of
the receptor is also visible [10]. CCR2B and FLNa colocalized
mainly at the plasma membrane and in filamentous structures
found within the cells (see zoom image in Figure 3A). FLNa forms
orthogonal intersecting actin filaments at the leading lamellae of
cells [16]. Interestingly, the colocalization of the receptor and
FLNa was prominent in lamellae at the leading edges of the cell.
Accordingly, staining of cells for actin with phalloidin showed that
CCR2B is associated with actin filament structures (Figure 3C)
and CCR2B co-localizes with actin and FLNa at the leading edge
of the cell, along the actin fibers and just at the tip of actin
filaments (see Figure 3D colocalization 1 with actin and 2 with
FLNa). Disruption of actin fibers with cytochalasin D (data not
shown) did not disrupt the binding of FLNa to the receptor, but
both proteins were relocated appearing in aggregates in the cell.
These results suggest that filamin A links the receptor to actin
Figure 1. Interaction between CCR2B and FLNa in yeast two-
hybrid. (A) The yeast expression plasmid pGBKT7-CCR2B47 (aa 314–
360) was co-transformed into S. cerevisiae strain AH109 together with
constructs encoding various repeats of human FLNa as indicated. (B)
Schematic representation of human FLNa indicating that the epitope
recognized by CCR2B maps between residues 2085–2647 of human
FLNa.
doi:10.1371/journal.pone.0012212.g001
CCR2B Interaction with FLNa
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(Figure 3B). Surprisingly though, CCR2B was also present at the
blebbing structures of the plasma membrane characteristic of the
M2 cells (see detailed image in Figure 3B).
Similar distribution of receptor in different sized clusters
at the membrane
The fact that the receptor may also be present in the plasma
membrane of filamin- deficient cells indicated that filamin A is not
necessary for stabilizing the receptor at the membrane. In order to
corroborate these results, M2 and A7 cells were immunostained
with anti-CCR2 antibody (the epitome is present at the N-terminal
tail of the receptor) without cell permeabilization, which allows the
visualization of receptors present only at the plasma membrane.
Figure 4A shows equal staining of receptors in both cell lines.
Subsequently, whole cell binding with
125I-MCP-1 (CCL2) also
demonstrated that the expression of the receptor in M2 and A7
cell membranes was equal (Figure 4B). Moreover, the affinity of
the ligand for the CCR2 receptor was similar: Ki of 0.860.2 nM
and 1.260.3 nM in A7 and M2 cells, respectively, which suggests
that filamin A does not affect the affinity of the ligand for the
receptor. These findings imply that filamin A is not necessary for
membrane localization of the receptor and is not required for the
activation of the receptor itself.
The chemokine receptors are distributed throughout the cell
surface and after ligand stimulation, they are rapidly recruited into
microdomain clusters at the plasma membrane [10]. Though
FLNa does not seem necessary for plasma membrane localization
it could help to induce clusters of receptor after ligand stimulation.
Employing fluorescent microscopy to image the upper layers of
non-permeabilized cells incubated with anti-FLAG antibody, we
studied the clustering of CCR2B present at the membrane of A7
and M2 cells after CCL2 stimulation (Figure 4C) by quantifiying
various size particles present in the membrane. Particles were
Figure 2. Interaction between CCR2B and FLNa and subcellular distribution of CCR2B with FLNa in monocytes. (A) Co-
immunoprecipitation of the Myc-tagged CCR2B tail fragment and full length FLNa. Lysates from A7 and M2 cells were added to the in vitro
transcription/translated CCR2B-tail (aa 314–360) and anti-c-Myc was used for immunoprecipitation. The translated parental expression vector was
used as control (C). IgG levels are indicated in the lower panel. (B) Coimmunoprecipitation of full length CCR2B with endogenous FLNa. HEK293 cells
were transfected with pcDNA3-FLAG-CCR2B (2B) or pcDNA3-FLAG (C). M2 anti-FLAG antibodies were used for immunoprecipitation. The CCR2B
dimer (D) and monomer (M) are indicated. FLNa and b-actin levels in the lysates are shown in the two lower panels. Blots are representative of at least
three independent experiments. (C) Mono Mac 1 cells (upper panel) and THP-1 (lower panel) cells were fixed and incubated with anti-CCR2 and
donkey anti-rabbit Alexa Fluor 488 and anti-filamin 1 and Texas Red goat anti-mouse. Images are from one single layer of the Z stacks. The
colocalization between CCR2B (green) and FLNa (red) was analyzed using Imaris colocalization software and is shown in white. Experiments were
done in duplicates and repeated three times.
doi:10.1371/journal.pone.0012212.g002
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R2=0.1420.5 mm; R3=0.523 mm) (Figure 4C and Figure S1).
Both cell lines showed a similar distribution of receptor in
different sized clusters at the membrane, although a reduction in
the overall number of particles upon ligand incubation was seen.
Grouping all particles with sizes above 0.07 mm (Figure 4D) also
indicated that the amount of surface-particles in A7 cells decreased
rapidly with time in the presence of ligand. In contrast, the
number of particles in M2 cells did not decrease so drastically.
Overall, these results imply that FLNa is neither necessary for the
localization of the receptor in the plasma membrane nor for
receptor clustering after CCL2 stimulation, but they suggest that
FLNa plays a specific role in CCL2-mediated internalization of
CCR2B into vesicles.
Filamin A is required for efficient internalization of the
CCR2B receptor
Since our previous results showed a reduction in the levels of
receptor in the plasma membrane after ligand addition whether
FLNa was present or not, we investigated the possible role of FLNa
in receptor endocytosis. First, the distribution of FLNa and the
receptor was analyzed after CCL2-stimulation in THP-1 and A7-
CCR2B cells (Figure S2A and B). CCL2 induced the redistribution
of the receptor from a disperse staining into a punctate pattern in
both THP-1 monocytes and A7-CCR2B cells. Receptor-enriched
type vesicles were clearly seen at 30 and 60 min after ligand
challenge, colocalizing with the punctate pattern of FLNa. In the
case of A7 cells, only the receptors localized originally at the plasma
membrane were followed. Initially, CCR2B was localized in ruffled
Figure 3. CCR2B localizes at the tips of actin filaments. CCR2B-A7 (A) and CCR2B-M2 (B) cells were fixed and incubated with antibodies and
analyzed as described before. (C) CCR2B-A7 cells were fixed, permeabilized and stained with anti-FLAG Cy3 and FITC-phalloidin. Images are from one
single layer of the Z stacks. The colocalization between CCR2B (red) and actin (green) was analyzed using Imaris colocalization software and is shown
in white. Bars,10 mm. (D) CCR2B-A7 cells were fixed, permeabilized and stained with anti-FLAG Cy3, FITC-phalloidin, mouse anti-FLNa followed by
goat anti-mouse Alexa633. Images show pseudo-colors for visualization purposes. Colocalization 1 (b-actin vs. CCR2B) and Colocalization 2 (FLNa vs.
CCR2B) were analyzed using Imaris colocalization software and are shown in white. Dotted lines in zoom 1 and zoom 2 mark the direction of the
stress fibers. Bars, 10 mm. Experiments were done in duplicates and repeated three times.
doi:10.1371/journal.pone.0012212.g003
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receptor and FLNa seemed to be located along the actin filament
structures. Therefore, these results suggest that the receptor
internalizes in endocytic vesicles upon CCL2 stimulation together
with FLNa and that vesicles may travel along actin structures
(Figure 3C zoom image).
To study the requirement of filamin A in CCR2B endocytosis,
the internalization of stimulated CCR2B in the FLNa-deficient
Figure 4. Equal levels of CCR2B in A7 and M2 cell surface by cluster analysis. (A) CCR2B-M2 and CCR2B-A7 cells incubated with anti-CCR2
and Alexa 488 anti-rabbit antibodies, were fixed without permeabilization. Bars, 10 mm. (B) Quantitative analysis of CCR2B binding at the surfaces of
M2 and A7 cells by radioligand binding. The data represented by means 6 SEM from three independent experiments, each performed in
sextuplicates. (C) A7 and M2 cells transfected with pcDNA3-FLAG-CCR2B and stimulated with 20 nM CCL2 for the times indicated were incubated
with anti-FLAG Cy3. Cells were fixed, permeabilized and treated with anti-rabbit Alexa Fluor 488. Z-stack Images were processed as maximum
intensity projection and analyzed with CellProfiler software (D). Statistical analysis was done as described in the Methods. Clusters above 0.07 mm
were quantified in M2 and A7 cells and plotted versus time after ligand addition. The graph represents the means 6 SEM, n=35 cells per cell type
and p values of p,0.05. Bars,10 mm. Experiments were done in duplicates and repeated three times.
doi:10.1371/journal.pone.0012212.g004
CCR2B Interaction with FLNa
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15 and 30 min of ligand incubation there was a poor
internalization, if any, in M2 compared to A7 cells (Figure 5). A
few cells showed some receptor in vesicles after ligand challenge
but, on average, vesicles in the M2 cells were closer to the plasma
membrane than in A7 cells and did not move deeper into the cell.
Therefore, in the absence of FLNa there was little recruitment of
the receptor to endocytic vesicles.
This effect could be due to a slower and inefficient
internalization of the receptor from the plasma membrane to
endocytic vesicles, which would leave some receptors at the
membrane, and/or to an impairment of vesicle transport after the
initial internalization from the membrane. To discern between the
two processes, internalization or vesicle transport, we followed the
receptors remaining at the plasma membrane after ligand
stimulation. We labeled the receptors remaining at the plasma
membrane after ligand stimulation with anti-FLAG-Cy3 antibod-
ies prior to cell permeabilization, whilst total receptor in the cell
was detected utilizing anti-FLAG-FITC antibodies after ligand
addition and cell permeabilization. The receptors that did not
undergo internalization after ligand stimulation would appear as
red or yellow. As expected (Figure 6), unstimulated A7 and M2
cells had receptors stained with both antibodies at the plasma
membrane (yellow staining). Fifteen minutes after addition of
ligand, all the receptors were internalized in A7 cells. Interestingly,
the red label reappeared in A7 cells at 30 min, which indicates that
receptors were present again at the plasma membrane, probably
due to receptor recycling. In contrast, M2 cells showed a marked
delay in the internalization since the receptor was present at the
plasma membrane even after 15 min of stimulation (see yellow
dots at the periphery of the cell). Some receptor did eventually
internalize and the dotted pattern was seen close to the plasma
membrane. In order to confirm these results, FLNa deficient M2
cells were restored for FLNa by transient transfection (Figure 7).
M2 cells that expressed FLNa (M2-FLNa) had more internalized
particles than M2 cells at 30 min after ligand challenge. In fact,
quantification of particles that were either at the plasma
membrane or inside the cell (i.e. close to or not close to the
membrane) showed that 30 min after stimulation there were
significantly more particles remaining at the plasma membrane in
M2 cells compared to A7 and M2-FLNa cells (Figure 7B). Also
worth noticing, was that the internalized particles in M2-FLNa
cells again contained both receptor and FLNa. These results,
together with previous data, demonstrate that FLNa is necessary
for efficient and rapid internalization from the plasma membrane
to endosomes.
Further evidence for the need of FLNa in receptor internali-
zation came from experiments where FLNa was knocked-down by
RNAi-mediated suppression using short interfering RNA (siRNA).
HEK293-CCR2B cells showed a reduction in the level of the
protein both in western blots and under confocal microscopy only
when transfected with FLNa siRNA but not with two different
control siRNAs (Figure 8 Aii and C). The depletion of FLNa by
siRNA blocked the internalization of CCR2B even at 30 min after
ligand stimulation (compare Figure 8 Ai to Aii). Quantification
and sorting of cells either as having receptor mainly in the
membrane or mainly in internalized particles, indicated that
silencing of FLNa expression completely altered the share of cells
with receptor in the membrane, an effect that was not observed in
presence of control siRNA (Figure 8 Ai, Aii and B). In HEK293-
CCR2B cells, FLNa once again colocalized together with the
receptor in internalized vesicles. Since cells treated with siRNA
against FLNa left the CCR2B receptor mainly at the plasma
membrane after ligand stimulation, we analyzed the activation of
intracellular calcium release, a well-known downstream cascade of
CCR2. Both cells treated with siRNA against FLNa or control
siRNA responded to CCL2 by elevating their intracellular calcium
levels (Figure S3). The levels of calcium increase were similar in
these cells supporting the idea that the receptor is activated in
absence of FLNa and desensitized by GRK2. Taken together these
results demonstrate that FLNa is necessary for the efficient
internalization of ligand-stimulated receptor into endocytic
vesicles.
The binding of b-arrestin-2 to stimulated CCR2B is not
affected by the lack of FLNa
Arrestin proteins promote clathrin-mediated internalization of
inactivated receptors to endosomal compartments. We previously
Figure 5. CCL2 activated CCR2B does not internalize efficiently
in FLNa-depleted M2 cells. To follow the internalization of the
CCR2B receptor, CCR2B-A7 and CCR2B-M2 cells grown onto coverslips
were incubated on ice with anti-FLAG-Cy3 prior to incubation with
20 nM CCL2 for the times indicated. After this, cells were fixed and
mounted. Images are representative of the majority of the cells and are
from one single layer of Z stacks. White dotted lines show the
boundaries of the cells. Experiments were done in duplicates and
repeated three times. Bars,10 mm.
doi:10.1371/journal.pone.0012212.g005
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and b-arrestin-2-dependent [9]. Since the M2-FLNa depleted cells
showed impairment in receptor internalization, we investigated
the pattern of localization of receptor and b-arrestin-2 in both A7
and M2 cells. Internalization of the receptor was followed with
FLAG-Cy3 pre-labeled antibody in cells expressing b-arrestin-2-
GFP. After stimulation, the CCR2B receptor localized in
endocytic vesicles as seen before. b-arrestin-2-GFP, which was
diffusely present in the cytoplasm without stimulation, relocated to
vesicles together with the receptor in both A7 and M2 cells (Figure
S4). Though in M2 cells, vesicles were clearly located closer to the
plasma membrane at late times. The binding of b-arrestin-2 to the
stimulated receptor seems not to be affected by the lack of FLNa.
Thus, the slow rate of receptor internalization cannot be due to
impairment in b-arrestin-2 binding to the activated receptor.
FLNa is necessary for CCL2-induced monocyte migration
To investigate the requirement of FLNa in CCL2-induced
THP-1 migration, we employed siRNAs to reduce the expression
of endogenous filamin A. THP-1 cells were transfected with a non-
specific control RNA and FLNa siRNA. Only cells transfected
with FLNa RNAi showed a decrease in the levels of endogenous
FLNa protein (Figure 9B). FLNa RNAi-transfected cells exhibited
a 40%69.15 reduction (n=4) in the migration response to CCL2
compared to cells incubated with control siRNA (Figure 9A).
These results indicate that selective inhibition of FLNa is sufficient
to induce an impairment in CCL2-mediated migration of THP-1
cells.
Discussion
The results presented demonstrate the association of FLNa with
the CCR2B receptor and supports the idea that FLNa is
responsible for the localization of the receptor in different dynamic
membrane structures. This includes the protrusion of lamellipodia
in migrating cells where receptor and FLNa protein colocalize and
the internalization step of receptor endocytosis. The lack of FLNa
not only disrupts receptor internalization but also the migration of
monocytes on a chemokine gradient.
There are currently over 60 identified interaction partners for
filamin A. These partners are of great functional diversity and
range from membrane receptors and ion channels to transcription
factors and intracellular signalling intermediates [11]. Of partic-
ular note is the fact that an increasing number of GPCRs have
been shown to associate with FLNa, including D2 and D3
Dopamine receptors [17,18], calcium sensing receptor [19,20],
metabotropic glutamate receptor type 7 [21], calcitonin receptor
[22] and m opioid receptor [23]. Unpublished results in our group
suggest that the other splice variant of the CCR2 receptor, namely
CCR2A, though it does not interact with the 19–24 domain of
filamin A may interact with other regions of the proteins. The C-
terminal tail region of FLNa is implicated in the majority of these
interactions. We have demonstrated that the association of FLNa
with the C-terminal tail of the CCR2B receptor comprises a region
including the tandem repeat 19. A recent study has identified
subgroups of filamin repeats (filamin subgroup A containing
repeats 4, 9, 12, 17, 19, 21 and 23) that share a conserved ligand-
Figure 6. Internalization of the CCR2B receptor is delayed in absence of filamin. To visualize the receptors remaining at the plasma
membrane, CCR2B-M2 and CCR2B-A7 were first incubated with 20 nM CCL2 for the times indicated and then treated with anti-FLAG-Cy3 prior to
permeabilization. After this, cells were permeabilized and treated with anti-FLAG-FITC antibody. Non-internalized receptors present at the plasma
membrane were detected in red and internalized receptor appears in green. Images are representative of the majority of the cells and are from one
single layer of the Z stacks. White dotted lines show the boundaries of the cells. Experiments were done in duplicates and repeated three times.
Bars,10 mm.
doi:10.1371/journal.pone.0012212.g006
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Curiously, CCR2B binds to at least one of the repeats of this group
(repeat 19) and shares some sequence homology with the
membrane receptors utilized in the analysis. Further mutation
analysis of its sequence will help to elucidate the amino acids
required for this interaction.
The interaction between filamin A and its protein partners plays
various roles: regulation of surface expression, stabilization,
clustering, degradation, internalization, recycling, anchoring to
actin, sequestration and cell motility. So in principle, the
interaction of the receptor with FLNa could fulfill several
functions. Driving the receptor to the plasma membrane and/or
stabilizing it would seem a likely possibility, but our results have
been quite conclusive showing the presence of receptor in the
plasma membrane of M2 melanoma FLNa-deficient cells and in
HEK293 cells depleted of FLNa. On the contrary, the interaction
between the stimulated receptor and FLNa is necessary for its
internalization in endocytic vesicles and consequently it is not
necessary for downstream calcium signaling. Cells depleted of
FLNa show a blockage in ligand-induced internalization, while
FLNa-deficient M2 cells display a reduced rate of internalization.
During recent years, there has been increasing evidence in
mammalian cells that the actin cytoskeleton participates directly in
membrane dynamics during clathrin-mediated endocytosis [25].
Actin appears in clathrin-coated structures at the plasma
membrane towards the end of the lifetime of the clathrin-coated
pits, thereby overlapping with the process of vesicle internalization
[26]. Actin polymerization is therefore tightly coupled, both
spatially and temporarily, to the vesicle-budding step of endocy-
tosis. On the other hand, it has been shown that invaginations
form without actin recruitment in mammalian cells, but that
efficient vesicle scission requires the involvement of actin [26]. In
fact, our results agree with this model of internalization since the
activated CCR2B receptor requires FLNa interaction to initiate
internalization and probably the link to actin fibers. Besides
binding to actin, FLNa will simultaneously interact with various
proteins, others receptors or factors necessary for endocytosis. It is
likely that by tethering the receptor to actin filaments, FLNa
Figure 7. The internalization rate of the CCL2-stimulated CCR2B is increased in FLNa-repleted M2 cells. (A) M2 cells were co-transfected
with pcDNA3-FLAG-CCR2B and pREP4-FLNa. Cells were further incubated with CCL2 for the times indicated and stained for CCR2B (red) and FLNa
(green). Colocalization is shown in white. Left panel shows control CCR2B-M2 cells without FLNa. Images are from one single layer of the Z stacks.
Experiments were done in duplicates and repeated three times. Bars, 10 mm. White dotted lines show the contour of the cells. (B) Quantification of
exogenous CCR2B in the cell membrane (mem) or inside (in) M2, A7 and M2-FLNa cells plotted as mean results 6 SEM (n=450 per time point).*:
p,0.05 for M2 T309 (in) vs. A7 T309(in) or M2-FLNa T309 (in).
doi:10.1371/journal.pone.0012212.g007
CCR2B Interaction with FLNa
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interacting proteins that are necessary for the efficient endocytosis
of the receptor into clathrin-coated pits (Figure 9C). Consequently,
FLNa can function as a signaling platform, coordinating the
association between multiple receptor/s and proteins localized at
the budding vesicles and the actin structures.
One of the interesting recent findings has been the fact that b-
arrestin proteins interact with FLNa [27,28]. The b-arrestin
binding site involves tandem repeat 22, which is close to the region
of binding to other GPCRs, including CCR2B. The binding of
FLNa to b-arrestin cooperates to activate the MAPK extracellular
signal-regulated kinase (ERK) downstream of GPCRs. In the case
of the D3R, the receptor is constitutively bound to both b-arrestin-
2 and FLNa [27]. Interestingly, the authors have demonstrated
that GRK activity acts as a rheostat to control the formation of
D3R-b-arrestin-filamin complexes. Though we have no data
proving the simultaneous interaction with the CCR2B, b-arrestin-
2 and FLNa proteins, we have shown that the CCL2-stimulated
receptor traffics in vesicles together with FLNa and also with b-
arrestin-2. It is possible that FLNa may facilitate the interactions of
the receptor with b-arrestin proteins (Figure 9C). In its absence, b-
arrestin-2 still binds to the receptor, but there is a delay in the
Figure 8. The internalization of the CCL2-stimulated CCR2B is significantly reduced after treatment with FLNa siRNA. (A) HEK293-
CCR2B cells were treated with 100 nM of FLNa siRNA (Ai) or negative control siRNA (Aii). Cells were further incubated with CCL2 for the times
indicated and stained for CCR2B (red) and FLNa (green). Colocalization is shown in white. Images are from one single layer of the Z stacks.
Experiments were done in duplicates and repeated three times. Bars,10 mm. White dotted lines indicate the contour of the cells. (B) Quantification of
CCR2B in the cell membrane (mem) or inside (in) the cell and plotted as mean results 6 SEM (n=450 per time point). *: p,0,01 for Ctrl- siRNA
(100nM) T309 (in) vs. FLNa siRNA (70 nM) T309 (in) or FLNa siRNA (100 nM) T309 (in). Data are from cells treated with 70 nM or 100 nM siRNA. (C)
Immunoblot quantification of FLNa knock-down in HEK293-CCR2B cells treated with 70 nM or 100 nM siRNA as indicated. Histogram represents the
mean intensity of the FLNa bands, normalized against the corresponding b-actin bands 6 SEM. Experiments were repeated twice with triplicate
samples.
doi:10.1371/journal.pone.0012212.g008
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the receptor, which could be due to the lack of simultaneous
FLNa binding to both CCR2B and b-arrestin-2. In this way,
FLNa could act as a major scaffolding protein for endocytic
protein complexes.
As mentioned before FLNA interacts with several other GPCRs
and membrane proteins. Though different roles have been given
for the different receptor-FLNa interactions, it is interesting that
FLNa affects the intracellular trafficking of various receptors. In
the case of the m opioid receptor, FLNa is implicated in its
recycling and degradation [23]. Endocytic sorting and recycling of
internalized calcitonin receptors are deficient in absence of FLNa
[22]. This is also the case for the calcium sensing receptor [29].
FLNa has also been shown to affect transferrin receptor late
endosome or lysosome targeting [30]. Though FLNa is crucial in
the initial step of CCL2-induced vesicle formation, we have also
observed the presence of activated receptor and FLNa in
trafficking endosomes, and the incorrect localization of late
endosomes in cells lacking FLNa which suggests that it may also
be involved in other steps of CCR2B-vesicle trafficking besides the
initial budding step of endosomes.
As mentioned before, the most likely mechanism by which
FLNa affects the initial step of vesicle budding may involve the
recruitment of other proteins together with the receptor to the
endocytic machinery. We have attempted to analyze the
implication of FLNa in receptor grouping at the membrane
utilizing a cluster analysis, but we have not observed any difference
in receptor distribution and cluster formation between FLNa-
deficient and FLNa-repleted cells following ligand stimulation. For
other receptors, FLNa is necessary for receptor clustering in the
plasma membrane as is the case of dopamine D2 and D3 receptors
[12]. For the D3R, FLNa is also essential for efficient sequestration
from the membrane in a GRK2-dependent mechanism [27,31].
FLNa also functions as a structural adaptor for CD4 and
chemokine co-receptor clustering in T cells [32]. In the case of
CCR2, another protein, FROUNT, has recently been shown to
bind to the receptor at the membrane and the authors
demonstrated that FROUNT is needed for receptor clustering
[10]. So it may be possible that FROUNT is the major player in
the receptor aggregation and that FLNa could act as a scaffold
protein that connects the receptor to other downstream proteins,
thereby facilitating both the formation and internalization of the
Figure 9. Chemotaxis in response to CCL2 is significantly reduced in THP-1 cells treated with FLNa siRNA. (A) Histogram of mean
chemotaxis migration results from THP-1 cells treated for 5 days with 100 nM of FLNa siRNA or negative control siRNA. Cells were left to migrate for
24 hours. Experiments were repeated four times. (B) Immunoblot of FLNa knock-down in THP-1 cells with 100 nM FLNa siRNA or negative control
siRNA as indicated. (C) Schematic model of CCL2-activated CCR2B in the cell membrane and during internalization. 1) Dimerized FLNa interacts with
the C-terminus of the CCR2B through at least repeat 19 and with b-arrestin through repeat 22. b-arrestin also binds the third intracellular loop of
CCR2B. In addition, FLNa interacts with actin to crosslink actin fibers.2 ) Vesicle-budding step of CCR2B-endocytosis. During CCL2-induced clathrin-
mediated endocytosis of CCR2B, FLNa links the receptor and arrestin molecules to actin. Actin polymerization is triggered when the clathrin coat and
the plasma membrane start to invaginate, and stops when vesicle scission occurs. 3) Endogenous vesicles can be propelled through the cytoskeleton
by actin comet tails, which might facilitate movement towards cytoskeletal structures or aid the fusion of endocytic organelles.
doi:10.1371/journal.pone.0012212.g009
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signaling pathways.
The main function of chemokines is to induce the migration of
cells to the sites of injury in the body. At the leading edge of the
cell, the actin cytoskeleton is reorganized to form lamellipodia,
generating a driving force for polarized migration. FLNa organizes
cortical actin filaments and dynamic three-dimensional networks
in the leading edges of migrating cells [10]. In fact, FLNa can
regulate RhoGTPase-mediated cytoskeleton remodelling, which is
for instance essential for monocyte migration. Here we find that
CCR2B receptor concentrates with FLNa particularly in the
leading edges of the membrane, more precisely, at the tip of actin
filaments in lamellipodia structures. More importantly, our results
demonstrate the requirement of FLNa for CCL2-induced cell
migration. A quite intriguing observation is the presence of
particles containing both receptor and FLNa along actin filaments
spread at the leading edge. It should be noted that, substantial
evidence is emerging suggesting the need of polarized trafficking
during cell motility [33]. Thus, our data strongly suggest that
FLNA could be responsible for localizing the receptor close to the
actin remodeling proteins. In summary, FLNa may, in coopera-
tion with other proteins, act as a scaffold for the spatial
organization of ligand-activated chemokine receptors at the
membrane at the leading edges of the cells by anchoring the
receptor to actin filaments.
In conclusion, FLNa emerges as an important protein which
links the CCR2B chemokine receptor to the actin filament
structures and controls the fate of the stimulated receptors in
dynamic membrane structures.
Methods
Cell culture
Human melanoma cell line M2 (lacking expression of FLNa) and
isogenic cell line A7 (stably expressing full-length FLNa) (provided
by J. Hartwig, Harvard Medical School, Boston, MA, USA) were
maintained in a-minimal essential medium supplemented with 8%
(v/v) newborn calf serum (NCS), 2% (v/v) fetal calf serum (FBS). A7
cells were cultured in the presence of 500 mg/ml G418. HEK293
cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% (v/v) FBS and 250 mg/ml G418. Flag-
CCR2B expressing HEK293 stable cells were made in the
laboratory (S. Butt, University of Bergen). THP-1 cells (ATCC,
Manassas, VA, USA) were maintained in RPM1 1640 medium
supplemented with 0.05 mM 2-mercaptoethanol, and FBS (10%).
DNA Constructs
A DNA sequence encoding a triple repetition of the terminal 47
residues of CCR2B (aa. 314–360) was cloned into the yeast
expression plasmid pGBKT7 to generate pGBKT7-CCR2B47.
The plasmid was constructed through a multistep procedure,
essentially asdescribed fortherhodopsinreceptor[34]. ThepMAL-
cRI plasmid used was kindly provided by J–Z. Chuang and C–H.
Sung (Cornell University Medical College, New York, USA). The
pACT2-FLNar16–19 and pACT2-FLNar18 were cordially sup-
plied by A. V. Binda (IBIOS, Pennsylvania State University College
of Medicine, Hershey, PA, USA). Expression plasmids for repeats
23 and 24 of FLNa in pGADT7, pGADT7-FLNar23 and
pGADT7-FLNar24 respectively, were made by PCR amplification
using pREP4-FLNa (Dr J. Hartwig, Harvard Medical School,
Boston, MA, USA) as a template. The pREP4-FLNa was also used
for exogenous FLNa expression. The pcDNA3-FLAG plasmid was
constructed by ligating the FLAG linker into pcDNA3 (Invitrogen,
CA, USA), while pcDNA3-FLAG-CCR2B was made using the
pcDNA3-ProFLAG-CCR2B [9].
Yeast two-hybrid assay
The Matchmaker GAL4 Two-hybrid System 3 (Clontech,
Saint-Germain-en-Laye, France) was used for the yeast two-hybrid
studies. The pGBKT7-CCR2B47 plasmid was utilized to screen a
human leukocyte Matchmaker cDNA library pre-transformed in
S. cerevisiae strain AH109 under medium stringency selection
conditions (synthetic dropout (SD) medium lacking Trp, Leu and
His, supplemented with 2.5 mM 3- amino-1,2,4-triazole (3-AT))
following the manufacturer’s instructions. Positive clones were
multiple re-streaked on medium and high stringency selection
media (SD medium lacking Trp, Leu, His and Ade, supplemented
with 2.5 mM 3-AT and 4 mg/ml X-a-gal) before purification and
sequencing of the harboured plasmids. Colonies sequentially co-
transformed with pGBKT7-CCR2B47 and various constructs
encoding FLNa repeats were plated out onto low stringency SD
plates (lacking Trp and Leu). Single isolated colonies from each
plate were picked, rigorously vortexed in 500 ml low stringency
medium, from which 5 ml drops were placed onto low (SD/22),
medium (SD/23) or high (SD/24) stringency selection plates and
incubated 3 days at 30uC.
Cell transfections and immunoprecipitations
For transient transfections, Fugene HD (Roche Diagnostics,
Basel, Switzerland) was used for the A7 and M2 cells, whilst
Effectene (Qiagen, Hilden, Germany) was used for the HEK293
cells; both methods were implemented according to the manufac-
turers’ instructions. For immunoprecipitations, cells were washed
in ice-cold phosphate buffered saline (PBS) and solubilized in 1%
Brij 96 V lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl,
0.5 mM EGTA, 1 mM MgCl2), containing 1 mM Na3VO4,
50 mM NaF, 10 mM Na4P2O7 and a cocktail of protease
inhibitors [35]. After clarification of the lysates, equal protein
amounts were immunoprecipitated at 4uC overnight with M2
mouse anti-FLAG (Sigma-Aldrich Co., St. Louis, MO, USA), pre-
coupled to Protein G-Sepharose beads. The immunocomplexes
washed in 1% and 0.05% Brij lysis buffer. The immunoprecip-
itates and lysate controls were resolved on SDS-PAGE and
transferred to nitrocellulose membranes. The presence of FLNa,
CCR2B and b-actin was detected using anti-filamin 1 (Santa Cruz
Biotechnologies, CA, USA), anti-FLAG (Sigma-Aldrich Co.) and
anti-b-actin (Abcam, Cambridge, UK) antibodies, respectively.
Blots were developed using an enhanced chemiluminescent
method (Pierce, Thermo Scientific, Rockford, USA) and scanned
using the LAS-3000 imaging system (Fujifilm, Tokyo, Japan).
In vitro binding studies
Myc-CCR2B47 was expressed from pGBKT7-CCR2B47 using a
T N TT 7Q u i c kC o u p l e dT r a n s c r i p t i on/Translation system (Promega
Biotech AB, Nacka, Sweden) according to the manufacturer’s
instructions. Parental expression vector pGBKT7 was used as control.
The in vitro reaction mixtures were mixed 1:1 in 1% Brij 96 V lysis
buffer. For binding studies, equal amounts of A7 or M2 cell lysates
from untransfected cells were incubated with the in vitro translated
pGBKT7 or pGBKT7-CCR2B47 mixture. Immunoprecipitation
was performed by adding IgG-free bovine serum albumin (BSA)
(Sigma-Aldrich Co.) and mouse anti-c-Myc (Zymed, CA, USA).
Immunostaining and confocal microscopy
A7 and M2 cells were seeded on coverslips the day before.
Immunofluorescence staining was done following different proto-
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ice-cold 3% paraformaldehyde solution and permeabilized in PBS
with 0.1% Tween 20 before staining with primary and secondary
antibodies; b) to detect the receptor in the plasma membrane, cells
were placed first on ice, incubated with primary antibodies before
being fixed, permeabilized and incubated with secondary
fluorescent antibodies; c) for internalization assays, cells treated
first with anti-FLAG M2 antibodies (Sigma-Aldrich Co.) at 4uC
were stimulated with 20 nM CCL2 (human MCP-1, PeproTech,
Rocky Hill, NJ) at 37uC for the times indicated before being fixed,
and incubated with secondary antibodies; d) to follow receptor
remaining in the plasma membrane, cells were first CCL2-
activated for the times indicated and fixed prior to treatment with
anti-FLAG-Cy3 (Sigma-Aldrich Co.). After permeabilization, cells
were incubated with anti-FLAG-FITC (Sigma-Aldrich Co.)
antibodies. Other antibodies and dyes used were: rabbit anti-
CCR2 (Abcam), Alexa Fluor 488 donkey anti-rabbit (Invitrogen),
mouse anti-filamin 1, Texas Red goat anti-mouse (Invitrogen),
FITC-phalloidin (Invitrogen) and Alexa Fluor 633 goat anti-mouse
(Invitrogen). For the cluster analysis, complete z-stacks of the cells
were taken and processed as maximum intensity projection.
CellProfiler software [36] was used in order to determine and
quantify the CCR2B particles in the cell surface. Data were
processed by GraphPad Prism software and results were plotted
representing the means 6 SEM. Two-way ANOVA, Bonferroni
or Mann Whitney tests were applied between cells and times (all
the groups), times (0’’ vs. 30’’ vs. 60’’) or stimulated cells (A7 vs.
M2 without time 0’’), respectively. To restore the A7 cell-like
phenotype, M2 cells were transiently transfected with pcDNA3-
FLAG CCR2B and pREP4-FLNa. The mean results of a total of
450 cells per treatment were plotted including 6 SEM and a t-test
was calculated with a p,0,05. Slides were mounted using Prolong
Gold mounting medium with or without DAPI (Invitrogen).
Optical sections were acquired using a Leica TCS SP2 AOBS
confocal system equipped with a 63x Ibd.BL oil objective.
Colocalization analyses were performed using the Imaris coloca-
lization module (Bitplane AG, Zurich, Switzerland).
Whole cell binding assay
Binding was carried out with (
125I- Human MCP-1 (CCL2)),
which was radio-iodinated using a standard protocol [37]. One
day after transfection, cells were trypsinized and plated onto 12
well plates at a density of 5610
4 cells per well. The following day,
cells were rinsed with HEPES-DMEM at 4uC, after which 0.5 ml
of media containing 50 000 cpm of
125I- Human MCP-1 alone or
together with increasing concentrations (10
211 M and 10
25 M) of
unlabelled peptide were added to the cells. The cells were
incubated at 4uC for 5 h, and subsequently washed with ice-cold
PBS to remove unbound peptide. The cells were then solubilized
with 0.5 ml 1 M NaOH for 10 min, transferred to counting tubes
and counted in a c-counter. The data was analyzed using
GraphPad Prism software.
CCR2B internalization assay in presence of FLNa siRNA
A synthetic FLNa-targeted siRNA oligoribonucleotide duplex
with symmetric 39TT overhang (FLNa siRNA sense sequence: 59-
AGGUGCUGCCUACUCAUGA-39, [38]) was purchased from
Dharmacon RNA Technologies (USA, Lafayette, CO). The
following two oligoribonucleotides were used as negative control:
siGENOME negative control siRNA #3 (Dharmacon), AllStars
negative control siRNA (Qiagen). HEK293 cells stably expressing
ProlactinFLAG-CCR2B were transiently transfected with 70 nM
or 100 nM synthetic control siRNA or FLNa siRNA using
Lipofectamine
TM 2000 reagent (Invitrogen), and incubated 5 days
at 37uC [38]. Cells were then washed in ice-cold PBS before being
solubilized in 0.5% NP-40 lysis buffer (50 mM Tris, pH 7.4,
150 mM NaCl, and 0.5% NP-40) containing 1 mM EDTA,
0.1 mM Na3VO4 and a cocktail of protease inhibitors. After
clarification, the lysates were resolved on SDS-PAGE and
transferred to nitrocellulose membranes. Cells to be used for the
internalization assay were trypsinised 4 days after transfection and
replated onto poly-L-lysine-coated glass coverslips. After 24 h,
cells were incubated with mouse anti-FLAG-M2-Cy3 antibody
(Sigma-Aldrich Co.) at 4uC and stimulated with 20 nM CCL2 at
37uC for the times indicated before being fixed, and incubated
with goat anti-FLNa (Santa Cruz Biotechnology, Inc.) followed by
FITC-conjugated mouse anti-goat (Jackson ImmunoResearch,
Suffolk, UK). 150 cells from each siRNA treatment per triplicate
were quantified and classified for main presence of CCR2B
receptor in the membrane or inside the cell. The mean results of a
total of 450 cells per treatment were plotted in a chart indicating 6
SEM and statistical t-test was calculated with a p,0,01.
Chemotaxis assay in presence of FLNa siRNA
THP-1 cells were transiently transfected with 100 nM FLNa
siRNA or siGENOME negative control siRNA #3 using the
Nucleofector kit V or L (Amaxa) according to the manufacturer’s
instructions and incubated 5 days at 37uC. 100 000 cells from each
sample were transferred to the upper chambers of a 24-well
chemotaxis chamber (6.5 mm inserts, pore size 3 or 5 mm)
(Corning, NY, USA) and 25 nM CCL2 in RPMI 1640
supplemented with 0.1% BSA was added to the lower chamber.
After 24 h at 37uC, filters were removed and trespassed cells were
quantified with the automatic detection mode in the Imaris
software by analysing pictures of the wells taken under a
NikonTE2000 microscope. Some of the samples treated with
siRNA were lysed in 0.5% NP-40 lysis buffer and subjected to
immunoblotting using rabbit anti-FLNa (Abcam) and anti-b-actin
antibodies.
Supporting Information
Figure S1 CCR2B cluster analysis in A7 and M2 cell surface.
Three different cluster sizes (R1=0.0720.14 mm;
R2=0.1420.5 mm and R3=0.523 mm) were analyzed for each
time point and cell type. The graph represents the means 6 SEM,
n=35 cells per cell type and p,0.05.
Found at: doi:10.1371/journal.pone.0012212.s001 (0.24 MB TIF)
Figure S2 Colocalization of CCR2B with FLNa during CCL2
treatment. THP-1 (A) and CCR2B-A7 cells (B) were grown onto
coverslips, incubated with rabbit anti-CCR2B or anti-FLAG-Cy3
and treated with 20 nM CCL2 for the times indicated. Cells were
fixed, permeabilized and treated with anti-rabbit Alexa Fluor 488
or goat anti-mouse Alexa Fluor 568. Images are from one single
layer of the Z stacks. The colocalization was analyzed using Imaris
colocalization software and is shown in white. White dotted lines
show the boundaries of the cells. Experiments were done in
duplicates and repeated three times. Bars, 1 mm.
Found at: doi:10.1371/journal.pone.0012212.s002 (0.92 MB TIF)
Figure S3 Filamin A is not necessary for downstream calcium
signaling from CCL2-activated CCR2B. HEK293 cells stably
expressing FLAG-CCR2B were left untreated or transiently
transfected with 100 nM synthetic control siRNA or FLNa siRNA
using Lipofectamine
TM 2000 reagent for 5 days. Cells were then
harvested and incubated for 20 min with 5 mM fluorescent
calcium indicator Fluo-4 AM (Invitrogen) in DMEM with 10%
FCS and 10 mM HEPES pH 7.4. Cells were washed, resuspended
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acquisition was done using the Accuri C6 Flow cytometer and
CFlowPlus software (Accuri Cytometers, Inc. Ann Arbor, MI
USA). Samples were analyzed for 1 min to take the baseline, then
for 5 min with 20 nM CCL2 and subsequently for 5 min with
2 mM ionomycin (transfected cells). Untransfected cells were left
untreated (negative control) or treated with 2 mM ionomycin
(Sigma-Aldrich Co.) (positive control). Data were analyzed using
FLOWJO software version 7.6.0 (Tree Star, Inc. Ashland, OR
USA) and are presented as Fluo-4 AM intensity over time.
Experiments were done in duplicates and repeated twice.
Found at: doi:10.1371/journal.pone.0012212.s003 (16.53 MB
TIF)
Figure S4 b-arrestin-2 colocalizes with the CCL2 activated
CCR2B in M2 and A7 cells. To follow CCR2B internalization
and b-arrrestin-2 co-distribution, A7 and M2 cells double-
transfected with pcDNA3-FLAG-CCR2B and b-arrestin-2-GFP
were placed on ice, treated with anti-FLAG-Cy3 antibodies and
stimulated with 20 nM CCL2. Images are representative of the
majority of the cells and are from one single layer of the Z stacks.
The colocalization was analyzed using Imaris colocalization
software and is shown in white. White dotted lines show the
boundaries of the cells. The experiment was repeated three times
with similar results. Bars, 10 mm.
Found at: doi:10.1371/journal.pone.0012212.s004 (1.14 MB TIF)
Acknowledgments
We would like to thank T. Ellingsen for technical support; M. Geli and J.
Saraste for scientific discussions, K. O. Skaftnesmo for helping in the
cluster analysis and Saima Butt for providing the CCR2B-293 stable cell
lines.
Author Contributions
Conceived and designed the experiments: JP AAK AMA. Performed the
experiments: LM JP MM BFK MMB. Analyzed the data: LM JP AMA.
Contributed reagents/materials/analysis tools: AMA. Wrote the paper:
LM AAK AMA.
References
1. Sallusto F, Baggiolini M (2008) Chemokines and leukocyte traffic. Nat Immunol
9: 949–952.
2. O’Hayre M, Salanga CL, Handel TM, Allen SJ (2008) Chemokines and cancer:
migration, intracellular signalling and intercellular communication in the
microenvironment. Biochem J 409: 635–649.
3. Thelen M, Stein JV (2008) How chemokines invite leukocytes to dance. Nat
Immunol 9: 953–959.
4. Vroon A, Heijnen CJ, Kavelaars A (2006) GRKs and arrestins: regulators of
migration and inflammation. J Leukoc Biol 80: 1214–1221.
5. Franci C, Gosling J, Tsou CL, Coughlin SR, Charo IF (1996) Phosphory-
lation by a G protein-coupled kinase inhibits signaling and promotes
internalization of the monocyte chemoattractant protein-1 receptor. Critical
role of carboxyl-tail serines/threonines in receptor function. J Immunol 157:
5606–5612.
6. Krupnick JG, Benovic JL (1998) The role of receptor kinases and arrestins in G
protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38: 289–319.
7. Aragay AM, Mellado M, Frade JM, Martin AM, Jimenez-Sainz MC, et al.
(1998) Monocyte chemoattractant protein-1-induced CCR2B receptor desensi-
tization mediated by the G protein-coupled receptor kinase 2. Proc Natl Acad
Sci U S A 95: 2985–2990.
8. Vroon A, Heijnen CJ, Lombardi MS, Cobelens PM, Mayor F, Jr., et al. (2004)
Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response
to CCL4. J Leukoc Biol 75: 901–909.
9. Jimenez-Sainz MC, Fast B, Mayor F, Jr., Aragay AM (2003) Signaling pathways
for monocyte chemoattractant protein 1-mediated extracellular signal-regulated
kinase activation. Mol Pharmacol 64: 773–782.
10. Terashima Y, Onai N, Murai M, Enomoto M, Poonpiriya V, et al. (2005)
Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated
monocyte chemotaxis. Nat Immunol 6: 827–835.
11. Popowicz GM, Schleicher M, Noegel AA, Holak TA (2006)
Filamins: promiscuous organizers of the cytoskeleton. Trends Biochem Sci 31:
411–419.
12. Lin R, Karpa K, Kabbani N, Goldman-Rakic P, Levenson R (2001) Dopamine
D2 and D3 receptors are linked to the actin cytoskeleton via interaction with
filamin A. Proc Natl Acad Sci U S A 98: 5258–5263.
13. Petrecca K, Miller DM, Shrier A (2000) Localization and enhanced current
density of the Kv4.2 potassium channel by interaction with the actin-binding
protein filamin. J Neurosci 20: 8736–8744.
14. Ohta Y, Suzuki N, Nakamura S, Hartwig JH, Stossel TP (1999) The small
GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci U S A 96:
2122–2128.
15. Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, et al. (2001) Filamins
as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol 2:
138–145.
16. Flanagan LA, Chou J, Falet H, Neujahr R, Hartwig JH, et al. (2001) Filamin A,
the Arp2/3 complex, and the morphology and function of cortical actin
filaments in human melanoma cells. J Cell Biol 155: 511–517.
17. Li M, Li C, Weingarten P, Bunzow JR, Grandy DK, et al. (2002) Association of
dopamine D(3) receptors with actin-binding protein 280 (ABP-280). Biochem
Pharmacol 63: 859–863.
18. Lin R, Canfield V, Levenson R (2002) Dominant negative mutants of filamin A
block cell surface expression of the D2 dopamine receptor. Pharmacology 66:
173–181.
19. Awata H, Huang C, Handlogten ME, Miller RT (2001) Interaction of the
calcium-sensing receptor and filamin, a potential scaffolding protein. J Biol
Chem 276: 34871–34879.
20. Hjalm G, MacLeod RJ, Kifor O, Chattopadhyay N, Brown EM (2001) Filamin-
A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an
interaction that participates in CaR-mediated activation of mitogen-activated
protein kinase. J Biol Chem 276: 34880–34887.
21. Enz R (2002) The actin-binding protein Filamin-A interacts with the
metabotropic glutamate receptor type 7. FEBS Lett 514: 184–188.
22. Seck T, Baron R, Horne WC (2003) Binding of filamin to the C-terminal tail of
the calcitonin receptor controls recycling. J Biol Chem 278: 10408–10416.
23. Onoprishvili I, Andria ML, Kramer HK, Ancevska-Taneva N, Hiller JM, et al.
(2003) Interaction between the mu opioid receptor and filamin A is involved in
receptor regulation and trafficking. Mol Pharmacol 64: 1092–1100.
24. Ithychanda SS, Hsu D, Li H, Yan L, Liu D, et al. (2009) Identification and
characterization of multiple similar ligand-binding repeats in filamin: implication
on filamin-mediated receptor clustering and cross-talk. J Biol Chem 284:
35113–35121.
25. Kaksonen M, Toret CP, Drubin DG (2005) A modular design for the clathrin-
and actin-mediated endocytosis machinery. Cell 123: 305–320.
26. Merrifield CJ, Feldman ME, Wan L, Almers W (2002) Imaging actin and
dynamin recruitment during invagination of single clathrin-coated pits. Nat Cell
Biol 4: 691–698.
27. Kim KM, Gainetdinov RR, Laporte SA, Caron MG, Barak LS (2005) G
protein-coupled receptor kinase regulates dopamine D3 receptor signaling by
modulating the stability of a receptor-filamin-beta-arrestin complex. A case of
autoreceptor regulation. J Biol Chem 280: 12774–12780.
28. Scott MG, Pierotti V, Storez H, Lindberg E, Thuret A, et al. (2006) Cooperative
regulation of extracellular signal-regulated kinase activation and cell shape
change by filamin A and beta-arrestins. Mol Cell Biol 26: 3432–3445.
29. Zhang M, Breitwieser GE (2005) High affinity interaction with filamin A
protects against calcium-sensing receptor degradation. J Biol Chem 280:
11140–11146.
30. Liu G, Thomas L, Warren RA, Enns CA, Cunningham CC, et al. (1997)
Cytoskeletal protein ABP-280 directs the intracellular trafficking of furin and
modulates proprotein processing in the endocytic pathway. J Cell Biol 139:
1719–1733.
31. Cho EY, Cho DI, Park JH, Kurose H, Caron MG, et al. (2007) Roles of protein
kinase C and actin-binding protein 280 in the regulation of intracellular
trafficking of dopamine D3 receptor. Mol Endocrinol 21: 2242–2254.
32. Jimenez-Baranda S, Gomez-Mouton C, Rojas A, Martinez-Prats L, Mira E, et
al. (2007) Filamin-A regulates actin-dependent clustering of HIV receptors. Nat
Cell Biol 9: 838–846.
33. Fletcher SJ, Rappoport JZ (2009) The role of vesicle trafficking in epithelial cell
motility. Biochem Soc Trans 37: 1072–1076.
34. Chuang JZ, Sung CH (1998) The cytoplasmic tail of rhodopsin acts as a novel
apical sorting signal in polarized MDCK cells. J Cell Biol 142: 1245–1256.
35. Contento RL, Molon B, Boularan C, Pozzan T, Manes S, et al. (2008) CXCR4-
CCR5: a couple modulating T cell functions. Proc Natl Acad Sci U S A 105:
10101–10106.
36. Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, et al. (2006)
CellProfiler: image analysis software for identifying and quantifying cell
phenotypes. Genome Biol 7: R100.
CCR2B Interaction with FLNa
PLoS ONE | www.plosone.org 13 August 2010 | Volume 5 | Issue 8 | e1221237. Fromme BJ, Coetsee M, Van Der Watt P, Chan MC, Sperling KM, et al. (2008)
High-affinity binding of southern African HIV type 1 subtype C envelope
protein, gp120, to the CCR5 coreceptor. AIDS Res Hum Retroviruses 24:
1527–1536.
38. Huang C, Wu Z, Hujer KM, Miller RT (2006) Silencing of filamin A gene
expression inhibits Ca2+ -sensing receptor signaling. FEBS Lett 580:
1795–1800.
CCR2B Interaction with FLNa
PLoS ONE | www.plosone.org 14 August 2010 | Volume 5 | Issue 8 | e12212